Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Scientists from the Max Planck Institute of Biochemistry and the Technical University of Munich have discovered new diagnostic markers of multiple sclerosis (MS) in cerebrospinal fluid (CSF). This was ...

People with persistent cognitive changes after mild COVID had elevated levels of immune activation and immunovascular markers in their cerebrospinal fluid (CSF) 10 months after acute SARS-CoV-2 ...

St. Louis, Nov. 15, 2005 -- A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward ...

The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using plasma samples. The assay requires the SPEAR UltraDet ...

Twenty-two patients were included (77% female; median age 60 years). Sixty-four percent had sensitizing EGFR mutations, and 32% had an atypical EGFR mutation. Thirteen of the 22 patients (59%) were ...

Specialized brain cells in the hypothalamus act as a disposal route for tau protein, shuttling it from cerebrospinal fluid into the bloodstream. When those cells break down, tau accumulates in the ...

These biomarker changes occurred alongside clinical stabilization or improvement, with no serious treatment-related adverse events.

In addition to brain imaging, laboratory analysis of cerebrospinal fluid is important for the diagnosis of multiple sclerosis (MS). In this study, proteomic analysis of this fluid has revealed a set ...